210 related articles for article (PubMed ID: 35880434)
41. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
Mao B; Xiao H; Zhang Z; Wang D; Wang G
Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
[TBL] [Abstract][Full Text] [Related]
42. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
43. Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells.
Wei S; Hao C; Li X; Zhao H; Chen J; Zhou Q
Tumour Biol; 2012 Aug; 33(4):1223-30. PubMed ID: 22392501
[TBL] [Abstract][Full Text] [Related]
44. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
45. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
[TBL] [Abstract][Full Text] [Related]
46. [Enhancement of B-cell translocation gene-2 inhibits proliferation and metastasis of colon cancer cells].
Jiang Z; Zhang L; Zhang L; Wang S; Zheng M; Li Y; Liu X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):330-5. PubMed ID: 26463021
[TBL] [Abstract][Full Text] [Related]
47. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
Xu Z; Wang Y; Xiong J; Cui F; Wang L; Peng H
J Cell Physiol; 2020 Apr; 235(4):3886-3893. PubMed ID: 31603257
[TBL] [Abstract][Full Text] [Related]
48. Lowly expressed LNC01136 fails to aid HIF-1α to induce BTG2 expression resulting in increased proliferation of retinal microvascular endothelial cells.
Zhang L; Wang X
Microvasc Res; 2022 May; 141():104315. PubMed ID: 35007537
[TBL] [Abstract][Full Text] [Related]
49. Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression.
Liu Y; Zou H; Xie Q; Zou L; Kong R; Mao B
Biomed Eng Online; 2021 Jul; 20(1):67. PubMed ID: 34217312
[TBL] [Abstract][Full Text] [Related]
50. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
Li DY; Lin FF; Li GP; Zeng FC
Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
[TBL] [Abstract][Full Text] [Related]
51. BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence.
Wheaton K; Muir J; Ma W; Benchimol S
Aging Cell; 2010 Oct; 9(5):747-60. PubMed ID: 20569234
[TBL] [Abstract][Full Text] [Related]
52. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
Li Q; Wang G; Zhang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
[TBL] [Abstract][Full Text] [Related]
53. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.
Lim SK; Choi YW; Lim IK; Park TJ
Clin Exp Metastasis; 2012 Dec; 29(8):901-13. PubMed ID: 22562501
[TBL] [Abstract][Full Text] [Related]
54. Physical exercise rescues defective neural stem cells and neurogenesis in the adult subventricular zone of Btg1 knockout mice.
Mastrorilli V; Scopa C; Saraulli D; Costanzi M; Scardigli R; Rouault JP; Farioli-Vecchioli S; Tirone F
Brain Struct Funct; 2017 Aug; 222(6):2855-2876. PubMed ID: 28247022
[TBL] [Abstract][Full Text] [Related]
55. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
56. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
[TBL] [Abstract][Full Text] [Related]
57. Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Chang PL; Chen WT; Juang HH
PLoS One; 2014; 9(2):e89117. PubMed ID: 24586533
[TBL] [Abstract][Full Text] [Related]
58. Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.
Wagener N; Bulkescher J; Macher-Goeppinger S; Karapanagiotou-Schenkel I; Hatiboglu G; Abdel-Rahim M; Abol-Enein H; Ghoneim MA; Bastian PJ; Müller SC; Haferkamp A; Hohenfellner M; Hoppe-Seyler F; Hoppe-Seyler K
Br J Cancer; 2013 Mar; 108(4):973-82. PubMed ID: 23299537
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
60. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J
Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
